Clearside Biomedical Inc. (CLSD)
NASDAQ: CLSD
· Real-Time Price · USD
0.90
0.01 (1.07%)
At close: May 13, 2025, 1:03 PM
Clearside Biomedical Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|
| License Revenue | 1.7M | 8.2M | 1.3M |
| License Revenue Growth | -79.27% | +530.77% | n/a |
| Product and Service, Other Revenue | 700K | n/a | n/a |
| Product and Service, Other Revenue Growth | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 3.06M | 2.84M | 3.08M | 2.82M | 2.95M | 2.64M | 3.13M | 3.16M | 3.17M | 2.35M | 2.79M | 3.46M | 3.14M | 2.82M | 2.82M | 2.89M | 2.65M | 2.37M | 2.61M | 3.12M | 3.65M | 3.78M | 5M | 4.38M | 4.18M | 3.87M | 3.56M | 3.07M | 2.44M | 2.3M | 2.29M | 2.67M | 2.39M | 1.63M | 970K | 1.27M | 1.22M | 1.06M | 3.02M | 1.25M |
| Selling, General, and Administrative Revenue Growth | +7.67% | -7.57% | +8.96% | -4.17% | +11.76% | -15.67% | -0.98% | -0.35% | +34.68% | -15.69% | -19.27% | +10.10% | +11.51% | 0.00% | -2.66% | +9.21% | +11.58% | -9.08% | -16.37% | -14.47% | -3.46% | -24.44% | +14.14% | +4.98% | +7.82% | +8.76% | +15.84% | +25.93% | +6.22% | +0.35% | -14.26% | +11.71% | +46.78% | +67.94% | -23.80% | +4.52% | +14.37% | -64.77% | +142.03% | n/a |
| Research and Development Revenue | 4.24M | 4.13M | 4.6M | 5.59M | 6.29M | 5.13M | 4.95M | 4.45M | 5.03M | 4.64M | 5.43M | 4.54M | 3.84M | 5.15M | 4.06M | 5.49M | 4.47M | 3.49M | 3.3M | 3.81M | 1.3M | 2.73M | 658K | 10.97M | 17.49M | 20.08M | 17.34M | 13.38M | 13.94M | 16.05M | 11.48M | 7.59M | 6.97M | 3.68M | 4.21M | 4.59M | 3.8M | 2.31M | 2.15M | 2.51M |
| Research and Development Revenue Growth | +2.81% | -10.32% | -17.61% | -11.22% | +22.57% | +3.76% | +11.17% | -11.46% | +8.41% | -14.60% | +19.71% | +18.12% | -25.39% | +26.77% | -26.05% | +22.76% | +28.14% | +5.76% | -13.41% | +192.03% | -52.16% | +314.59% | -94.00% | -37.28% | -12.93% | +15.80% | +29.63% | -3.99% | -13.18% | +39.83% | +51.23% | +8.88% | +89.33% | -12.60% | -8.19% | +20.83% | +64.49% | +7.55% | -14.39% | n/a |